ADAR RNA modifications, the epitranscriptome and innate immunity

J Quin, J Sedmík, D Vukić, A Khan, LP Keegan… - Trends in biochemical …, 2021 - cell.com
Modified bases act as marks on cellular RNAs so that they can be distinguished from foreign
RNAs, reducing innate immune responses to endogenous RNA. In humans, mutations …

Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: an update

M Kono, M Akiyama - Journal of Dermatological Science, 2019 - Elsevier
Dyschromatosis symmetrica hereditaria (DSH) and reticulate acropigmentation of Kitamura
(RAK) are rare, inherited pigmentary diseases. DSH shows a mixture of pigmented and …

The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench

MJ Hofer, N Modesti, NG Coufal, Q Wang… - Immunological …, 2024 - Wiley Online Library
Aicardi‐Goutières syndrome (AGS) is a progressive genetic encephalopathy caused by
pathogenic mutations in genes controlling cellular anti‐viral responses and nucleic acid …

EpisomiR, a new family of miRNAs, and its possible roles in human diseases

Y Arao, M Nakayama, Y Tsuji, Y Hamano, C Otsuka… - Biomedicines, 2022 - mdpi.com
MicroRNAs (miRNAs) are synthesized through a canonical pathway and play a role in
human diseases, such as cancers and cardiovascular, neurodegenerative, psychiatric, and …

Movement disorders in ADAR1 disease: Insights from a comprehensive cohort

G Di Lazzaro, F Graziola, A Sancesario… - Parkinsonism & Related …, 2020 - Elsevier
ADAR1 variants are associated to rare and heterogenous neurological conditions, including
Aicardi-Goutières syndrome type 6, bilateral striatal necrosis, and dyschromatosis …

Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria

M Suganuma, M Kono, M Yamanaka… - Pigment Cell & …, 2020 - Wiley Online Library
Dyschromatosis symmetrica hereditaria (DSH) is a pigmentary genodermatosis caused by
mutations in ADAR1. In this study, we performed mutation analysis on a family that included …

Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen

M Kono, T Okamoto, T Takeichi, Y Muro… - European Journal of …, 2018 - jle.com
Dyschromatosis symmetrica hereditaria (DSH) is caused by a heterozygous ADAR1
mutation [1] and is characterized by a mixture of hyper-and hypo-pigmented small macules …

RNA editing in interferonopathies

L Frassinelli, S Galardi, SA Ciafrè… - RNA Editing: Methods and …, 2021 - Springer
The type I interferonopathies comprise a heterogenous group of monogenic diseases
associated with a constitutive activation of type I interferon signaling. The elucidation of the …

Dyschromatosis symmetrica hereditaria with chilblains due to a novel two‐amino‐acid deletion in the double‐stranded RNA‐binding domain of ADAR1.

M Kono, M Suganuma, T Takeichi… - Journal of the …, 2018 - search.ebscohost.com
The article presents a case study on the detection of ADAR1 mutation in a seven-year-old
girl with skin disease dyschromatosis symmetrica hereditaria and chilblains due to the …

Identification of Two Novel Frameshift Mutations of the ADAR1 Gene in Two Chinese Families With Dyschromatosis Symmetrica Hereditaria

X Ning, S Xiao, Y Zhang - Indian Journal of Dermatology, 2022 - journals.lww.com
Background: Dyschromatosis symmetrica hereditaria (DSH) is a rare autosomal dominant
skin disease. The mutation of the ADAR1 gene is the pathogenesis of this disorder. Aims …